Search

everythinglearnresearchcommunity

for

Search:↓

Some dibenzo compounds might help treat cancer with fewer side effects.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.